Compound paracetamol and amantadine tablets

Acetaminophen can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects; amantadine can resist "sub-type A" influenza virus and inhibit virus reproduction; caffeine is a central nervous system stimulant, which can enhance the antipyretic and analgesic effects of acetaminophen, and can reduce the central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs; chlorpheniramine maleate is an antiallergic drug that can relieve symptoms such as runny nose, nasal congestion, and sneezing; artificial bezoar has antipyretic and tranquilizing effects. The above drugs are combined to make a compound prescription, which can enhance the antipyretic and analgesic effects and relieve or improve various symptoms caused by colds.

This product is a compound preparation. Each tablet contains 250 mg of acetaminophen, 100 mg of amantadine hydrochloride, 10 mg of artificial bezoar, 15 mg of caffeine, and 2 mg of chlorpheniramine maleate.

This product is light yellow tablet.

It is suitable for relieving symptoms such as fever, headache, sore limbs, sneezing, runny nose, nasal congestion, and sore throat caused by the common cold and influenza.

Oral administration. Adults, 1 tablet at a time, 2 times a day.

Sometimes there are mild dizziness, fatigue, nausea, upper abdominal discomfort, dry mouth, lack of appetite and rash, which can recover on their own.

It is contraindicated in patients with severe hepatic and renal impairment.

Precautions for children: Children under 1 year old are prohibited to use. Precautions for pregnancy and lactation: The amantadine, acetaminophen, and artificial bezoar in this product can all pass through the placenta, are toxic to the embryo and can cause teratogenesis, and may have adverse effects on the fetus; except for the artificial bezoar, which is unknown, all other ingredients can be secreted through breast milk, so pregnant and lactating women are prohibited to use. Precautions for the elderly: Use with caution or reduce the dosage appropriately.

1. When used with other antipyretic analgesics, the risk of nephrotoxicity may be increased. 2. This product should not be used with chloramphenicol, barbiturates (such as phenobarbital), etc. 3. If used with other drugs at the same time, drug interactions may occur. Please consult a physician or pharmacist for details.

seal

Compound

36 months

Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.

• Founded in:

  1999-03-03

• Address:

  No. 2 Dashizhi Road, Nan'an Economic and Technological Development Zone, Chongqing

• Tax NO.:

  915001082031636780

• Registered Funds:

  110.6375 million yuan

• Website:

  Log in to view

• Email:

  Log in to view